^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Simulect (basiliximab)

    i
    Other names: CHI 621, Chimeric RFT5, chRFT5, SDZ CHI 621, CHI-621, CHI621
    Associations
    News
    Trials
    Company:
    Novartis
    Drug class:
    CD25 inhibitor
    Related drugs:
    Associations
    News
    Trials